Vender, Ron
32  results:
Search for persons X
?
2

Age affects drug survival rates of interleukin (IL)‐17 and ..:

Chiricozzi, Andrea ; Coscarella, Giulia ; Puig, Luis...
Journal of the European Academy of Dermatology and Venereology.  , 2024
 
?
 
?
 
?
5

Baseline Characteristics of Canadian Patients in the Psoria..:

Gooderham, Melinda J. ; Bissonnette, Robert ; Kalia, Sunil...
Journal of Cutaneous Medicine and Surgery.  27 (2023)  6 - p. 594-600 , 2023
 
?
6

A Systematic Review and Meta-Analysis of Injection Site Rea..:

Kim, Patrick J. ; Lansang, Rafael Paolo ; Vender, Ron
Journal of Cutaneous Medicine and Surgery.  27 (2023)  4 - p. 358-367 , 2023
 
?
7

Bimekizumab efficacy and safety through three years in pati..:

Thaçi, Diamant ; Vender, Ron ; De Rie, Menno...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s68 , 2022
 
?
10

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors f..:

Torres, Tiago ; Puig, Luis ; Vender, Ron...
American Journal of Clinical Dermatology.  23 (2022)  6 - p. 891-904 , 2022
 
?
11

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for P..:

Torres, Tiago ; Puig, Luis ; Vender, Ron...
American Journal of Clinical Dermatology.  22 (2021)  4 - p. 567-579 , 2021
 
?
12

27859 Maintenance of response through up to 5-years of cont..:

Reich, Kristian ; Armstrong, April W. ; Langley, Richard...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB163 , 2021
 
?
13

Brodalumab success in patients with moderate-to-severe psor..:

Yeung, Jensen ; Vender, Ron ; Turchin, Irina...
Journal of the American Academy of Dermatology.  84 (2021)  4 - p. 1169-1171 , 2021
 
?
14

Treatment discontinuation and rate of disease transmission ..:

Georgakopoulos, Jorge R. ; Mufti, Asfandyar ; Vender, Ron.
Journal of the American Academy of Dermatology.  83 (2020)  4 - p. 1212-1214 , 2020
 
?
15

15188 Clinical responses by self-reported PsA status at bas..:

Reich, Kristian ; Gottlieb, Alice B. ; Guenther, Lyn...
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB31 , 2020
 
1-15